• 2239 Citations
  • 25 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where G. Mikala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
L-Type Calcium Channels Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization Medicine & Life Sciences
Calcium Channels Medicine & Life Sciences
Xenopus Medicine & Life Sciences
Oocytes Medicine & Life Sciences
Phosphorylation Chemical Compounds
Granulocyte Colony-Stimulating Factor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 2239 Citations
  • 25 h-Index
  • 79 Article
  • 1 Chapter
  • 1 Review article

Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients

Avivi, I., Cohen, Y. C., Suska, A., Shragai, T., Mikala, G., Garderet, L., Seny, G. M., Glickman, S., Jayabalan, D. S., Niesvizky, R., Gozzetti, A., Wiśniewska-Piąty, K., Waszczuk-Gajda, A., Usnarska-Zubkiewicz, L., Hus, I., Guzicka, R., Radocha, J., Milunovic, V., Davila, J., Gentile, M. & 2 others, Castillo, J. J. & Jurczyszyn, A., Jan 1 2019, In : American Journal of Hematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Multicenter Studies
Retrospective Studies
Recurrence
Plasmacytoma

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Lovas, S., Varga, G., Farkas, P., Masszi, T., Wohner, N., Bereczki, Á., Adamkovich, N., Borbényi, Z., Szomor, Á., Alizadeh, H., Szaleczky, E., Wolf, K., Schneider, T., Plander, M., Szendrei, T., Csacsovszki, O., Csukly, Z., Rajnics, P., Egyed, M., Nagy, Z. & 4 others, Rejtő, L., Illés, A., Mikala, G. & Váróczy, L., Jan 1 2019, In : International Journal of Hematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Safety
Disease-Free Survival
Kidney
Therapeutics

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Varga, G., Nagy, Z., Demeter, J., Kosztolányi, S., Szomor, Á., Alizadeh, H., Deák, B., Schneider, T., Plander, M., Szendrei, T., Váróczy, L., Illés, A., Bátai, Á., Pető, M. & Mikala, G., Jan 1 2019, In : Pathology and Oncology Research.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Safety
Clinical Protocols
Disease-Free Survival